Metropolis Healthcare Q2 net profit rises 13% on TruHealth, specialty portfolio growth
Earnings before interest, tax, depreciation, and amortisation (EBITDA) rose 20.5% year-on-year to ₹108.6 crore, up from ₹90.1 crore in the same period last year. Shares of Metropolis Healthcare Ltd ended at ₹2,028.60, up by ₹24.15, or 1.20%, on the BSE.